Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer
Cell Biochemistry and Biophysics · 2024
DOI: 10.1007/s12013-024-01296-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Biochemistry and Biophysics, 2024. Verfasst von Ping Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Medical, Xinyang Vocational and Technical College, Xinyang, 464000, Henan, China. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Drug Resistance, Neoplasm, Lentinan, Lung Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Key Research and Development and Promotion Project of Henan Province (Scientific and Technological Project).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medical, Xinyang Vocational and Technical College, Xinyang, 464000, Henan, China.
- Department of Cancer Surgery, Xinyang Central Hospital, Xinyang, 464000, Henan, China.
- School of Inspection, Xinyang Vocational and Technical College, Xinyang, 464000, Henan, China.
- Department of Medical Oncology, Xinyang Central Hospital, Xinyang, 464000, Henan, China.
- School of Inspection, Xinyang Vocational and Technical College, Xinyang, 464000, Henan, China. taolingtl2019@163.com.
Förderung
- Key Research and Development and Promotion Project of Henan Province (Scientific and Technological Project)
Zitieren
APA
Tian, P., Du, D., Yang, L., Zhou, N., & Tao, L. (2024). Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer. Cell Biochemistry and Biophysics. https://doi.org/10.1007/s12013-024-01296-8
Vancouver
Tian P, Du D, Yang L, Zhou N, Tao L. Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer. Cell Biochemistry and Biophysics. 2024. doi:10.1007/s12013-024-01296-8
BibTeX
@article{Tian2024,
author = {Tian, Ping and Du, Dajun and Yang, Li and Zhou, Nan and Tao, Ling},
title = {Lentinan mitigates pemetrexed chemoresistance by the PI3K/Akt pathway in non-small cell lung cancer},
journal = {Cell Biochemistry and Biophysics},
year = {2024},
doi = {10.1007/s12013-024-01296-8}
}
EUVIMED